Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacteria in the Urinary Tract (UTI Bacteria)
- Target
- UTI Bacteria
- Molecular classification
- Bacteria, Gram-negative bacteria, Gram-positive bacteria
01
Overview
Bacteria in the urinary tract, primarily Gram-negative rods like Escherichia coli, are the main cause of urinary tract infections (UTIs). These bacteria utilize specific adhesins and receptors, such as uroplakins, to colonize the urinary tract and establish infection. Other common causative agents include Staphylococcus saprophyticus, Klebsiella pneumoniae, Proteus mirabilis, and Enterococcus faecalis. Treatment strategies mainly revolve around antibiotics, but increasing antibiotic resistance poses a significant challenge.
- Other names
- UropathogensUrinary Tract Infection BacteriaBacteria causing UTIs
02
Mechanism of action
Various, depending on the antibiotic. Includes inhibition of bacterial cell wall synthesis, DNA replication, protein synthesis, or folate synthesis.
03
Biological functions
Adhesion to host cellsColonization of urinary tractBiofilm formationUrease productionInvasion of urinary tract tissues
04
Disease associations
Urinary Tract Infections (UTIs)CystitisPyelonephritisUrethritisComplicated UTIsUncomplicated UTIs
05
Safety considerations
Antibiotic resistanceCollateral damage to microbiomeAdverse drug reactionsClostridium difficile infection
06
Interacting drugs
Antibiotics (e.g., Fluoroquinolones, Trimethoprim-Sulfamethoxazole, Nitrofurantoin, Cephalosporins)
1 more in the full profile.
07
Biomarkers
Bacterial load in urineWhite blood cells in urineNitrites in urineLeukocyte esterase in urine
Beyond the preview
Go deeper on Bacteria in the Urinary Tract (UTI Bacteria).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bacteria in the Urinary Tract (UTI Bacteria).